We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approves Avastin for the Most Common Type of Kidney Cancer

News   Aug 13, 2009

 
FDA Approves Avastin for the Most Common Type of Kidney Cancer
 
 
 

RELATED ARTICLES

From the Cosmos to the Clinic: A New Type of DNA Is Created

News

A new form of synthetic DNA expands the information density of the genetic code, that likely preserves its capability for supporting life, according to a new study. By expanding the genetic alphabet from four letters to eight, researchers demonstrate the ability to double the information density in DNA.

READ MORE

Therapeutic Approach to Tackle African Sleeping Sickness

News

Scientists working in a range of disciplines joined forces to identify a new approach to combat African sleeping sickness. Their research revealed a promising strategy to develop a suitable agent. This novel concept could also be employed in the future rational design of drugs for the treatment of other diseases.

READ MORE

“Smart Drug” Shows Promise for Metastatic Triple-Negative Breast Cancer

News

A new "smart drug" has shown promise for women with metastatic triple-negative breast cancer, based on data from a clinical trial at NewYork-Presbyterian/Columbia's Herbert Irving Comprehensive Cancer Center and other centers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE